TY - JOUR
T1 - Cardiovascular Risk Reduction in High-Risk Pediatric Patients
T2 - A Scientific Statement From the American Heart Association
AU - De Ferranti, Sarah D.
AU - Steinberger, Julia
AU - Ameduri, Rebecca
AU - Baker, Annette
AU - Gooding, Holly
AU - Kelly, Aaron S.
AU - Mietus-Snyder, Michele
AU - Mitsnefes, Mark M.
AU - Peterson, Amy L.
AU - St-Pierre, Julie
AU - Urbina, Elaine M.
AU - Zachariah, Justin P.
AU - Zaidi, Ali N.
N1 - Publisher Copyright:
© 2019 American Heart Association, Inc.
PY - 2019/3/26
Y1 - 2019/3/26
N2 - This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis. For each topic, the evidence for accelerated acquired coronary artery disease and stroke in childhood and adolescence and the evidence for benefit of interventions in youth will be reviewed. Children and adolescents may be at higher risk for cardiovascular disease because of significant atherosclerotic or arteriosclerotic risk factors, high-risk conditions that promote atherosclerosis, or coronary artery or other cardiac or vascular abnormalities that make the individual more vulnerable to the adverse effects of traditional cardiovascular risk factors. Existing scientific statements and guidelines will be referenced when applicable, and suggestions for risk identification and reduction specific to each setting will be described. This statement is directed toward pediatric cardiologists, primary care providers, and subspecialists who provide clinical care for these young patients. The focus will be on management and justification for management, minimizing information on pathophysiology and epidemiology.
AB - This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis. For each topic, the evidence for accelerated acquired coronary artery disease and stroke in childhood and adolescence and the evidence for benefit of interventions in youth will be reviewed. Children and adolescents may be at higher risk for cardiovascular disease because of significant atherosclerotic or arteriosclerotic risk factors, high-risk conditions that promote atherosclerosis, or coronary artery or other cardiac or vascular abnormalities that make the individual more vulnerable to the adverse effects of traditional cardiovascular risk factors. Existing scientific statements and guidelines will be referenced when applicable, and suggestions for risk identification and reduction specific to each setting will be described. This statement is directed toward pediatric cardiologists, primary care providers, and subspecialists who provide clinical care for these young patients. The focus will be on management and justification for management, minimizing information on pathophysiology and epidemiology.
KW - AHA Scientific Statements
KW - adolescence
KW - cardiovascular diseases
KW - pediatrics
KW - risk management
KW - risk reduction
UR - http://www.scopus.com/inward/record.url?scp=85063712770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063712770&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000000618
DO - 10.1161/CIR.0000000000000618
M3 - Article
C2 - 30798614
AN - SCOPUS:85063712770
SN - 0009-7322
VL - 139
SP - E603-E634
JO - Circulation
JF - Circulation
IS - 13
ER -